BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
San Diego Rx Abuse Task Force recently hosted the marijuana drug interactions media event, which was live-streamed on Facebook on September 9. This is an innovative project – probably the first of its kind – alerting consumers on drug interactions with cannabis products and evaluating the importance of this information to the public. Watch online
Hear a discussion with Dr. Bertha Madras on High Truths on Drugs and Addiction, Episode #12. Dr. Madras is an IASIC scientific advisor, Harvard Professor and former White House Office of National Drug Control Policy Deputy Director of Demand Reduction. In episode #12, Dr. Madras explains the importance and possible prevention of drug use. The
Research from 33,000 adults ages 18 – 44 shows that using cannabis increases your risk of a heart attack. It doesn’t matter if you smoke it, vape it, or eat it. Cannabis can hurt your heart. Read the full article here: https://www.cnn.com/2021/09/07/health/cannabis-heart-attack-young-adult-study-wellness/ Read the study referenced in the article: https://www.cmaj.ca/content/193/35/E1377
Seventeen pharmacies in San Diego County will soon begin distributing flyers to patients warning of potential interactions between prescription medications and cannabis. The pilot program will provide information to patients about possible cannabis-medication interactions, as well as seek feedback through an online survey to evaluate whether patients find such information useful. View the IASIC library
Have we learned our lessons from the opioid epidemic? Pushing pain pills led to increased addiction, deaths and crime. What’s happening now with marijuana? Read the full article here: https://www.nationalreview.com/2021/08/libertarians-were-wrong-about-marijuana-legalization/
Cancer patients are wise to avoid cannabis products given their immunosuppressed body and the carcinogens and contaminants in cannabis. View the IASIC library to learn about contaminants, cancer, and more. Read the full article here: https://www.newswise.com/articles/cancer-patients-use-less-marijuana-than-general-public?sc=sptn
You just don’t know what you are buying. Consumer protection exists by buying prescriptions from a pharmacy. If you see a USP seal on supplements you can trust that the products went through a standards process. Otherwise- you don’t know what you are getting. In this story pot brownies had fentanyl. Visit the IASIC1 library
IASIC, the International Academy on the Science and Impact of Cannabis, is a medical organization of doctors who educate on marijuana based on the scientific and medical literature. IASIC is a non-partisan and non-political group created to facilitate informed decisions when considering cannabis policy and law. Visit the IASIC Library to few medical literature on the harms
Cannabis Use Disorder (CUD) was associated with a 47%-52% increased likelihood of arrhythmia hospitalizations in the younger population. The risk of association was controlled for confounders including other substances. Atrial fibrillation was the most prevalent arrhythmia raising concerns for stroke and other embolic events. This large national study compared 570,000 patients ages 15-54 who were admitted to
Patients undergoing percutaneous coronary intervention (PCI) after recent marijuana smoking tended to have different complications than non-users, researchers at the University of Michigan in Ann Arbor found. The researchers analyzed Blue Cross Blue Shield of Michigan Cardiovascular Consortium PCI registry data between January 1, 2013, and September 30, 2016. Read the full article here: https://www.medpagetoday.com/cardiology/pci/94060? For
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
